Id |
Subject |
Object |
Predicate |
Lexical cue |
T121 |
0-205 |
Sentence |
denotes |
The differences between patients with and without COVID-19 for all 67 features (41 imaging and 26 critical clinical features) are shown in Tables 1 and 2 and the Supplementary Materials (Tables E3 and E4). |
T122 |
206-353 |
Sentence |
denotes |
The differences between the primary cohort and validation cohort for the same features are shown in the Supplementary Materials (Tables E5 and E6). |
T123 |
354-511 |
Sentence |
denotes |
All characteristics except fatigue and white blood cell count in the CR model presented no significant difference between the primary and validation cohorts. |
T124 |
512-623 |
Sentence |
denotes |
A total of 1745 lesions were identified, with 1062 from the COVID-19 group and 683 from the non-COVID-19 group. |
T125 |
624-703 |
Sentence |
denotes |
Table 1 Radiological semantic features of patients in COVID-19 and non-COVID-19 |
T126 |
704-759 |
Sentence |
denotes |
Feature Non-COVID-19 (n = 66) COVID-19 (n = 70) p value |
T127 |
760-778 |
Sentence |
denotes |
Number of pure GGO |
T128 |
779-831 |
Sentence |
denotes |
Total# 1.00 (0.00, 5.05) 3.50 (0.95, 8.05) 0.018b* |
T129 |
832-894 |
Sentence |
denotes |
Peripheral area# 1.00 (0.00, 4.05) 2.00 (0.00, 6.05) 0.032b* |
T130 |
895-982 |
Sentence |
denotes |
Central/both peripheral and central area# 0.00 (0.00, 0.00) 0.00 (0.00, 2.00) 0.001b* |
T131 |
983-1002 |
Sentence |
denotes |
Number of mixed GGO |
T132 |
1003-1055 |
Sentence |
denotes |
Total# 1.00 (0.00, 3.05) 3.00 (1.00, 9.00) 0.001b* |
T133 |
1056-1120 |
Sentence |
denotes |
Peripheral area# 0.00 (0.00, 2.00) 2.50 (1.00, 6.00) < 0.001b* |
T134 |
1121-1207 |
Sentence |
denotes |
Central/both peripheral and central area# 0.00 (0.00, 1.05) 0.00 (0.00, 2.00) 0.657b |
T135 |
1208-1237 |
Sentence |
denotes |
Total number of consolidation |
T136 |
1238-1298 |
Sentence |
denotes |
Consolidation# 1.00 (0.00, 3.00) 0.00 (0.00, 0.05) 0.001b* |
T137 |
1299-1363 |
Sentence |
denotes |
Pure solid nodules# 0.00 (0.00, 0.00) 0.00 (0.00, 0.00) 0.309b |
T138 |
1364-1433 |
Sentence |
denotes |
Solid nodules with GGO# 0.00 (0.00, 0.00) 0.00 (0.00, 1.00) 0.033b* |
T139 |
1434-1457 |
Sentence |
denotes |
Total number of lesions |
T140 |
1458-1520 |
Sentence |
denotes |
Peripheral area# 5.00 (2.00, 9.05) 7.00 (2.00, 13.00) 0.112b |
T141 |
1521-1579 |
Sentence |
denotes |
Central area# 0.00 (0.00, 3.00) 0.00 (0.00, 1.05) 0.960b |
T142 |
1580-1658 |
Sentence |
denotes |
Both peripheral and central area# 0.00 (0.00, 2.00) 0.00 (0.00, 2.05) 0.582b |
T143 |
1659-1697 |
Sentence |
denotes |
Interlobular septal thickening 0.009a* |
T144 |
1698-1732 |
Sentence |
denotes |
Negative 44 (66.67%) 31 (44.29%) |
T145 |
1733-1767 |
Sentence |
denotes |
Positive 22 (33.33%) 39 (55.71%) |
T146 |
1768-1798 |
Sentence |
denotes |
Crazy paving pattern < 0.001a* |
T147 |
1799-1833 |
Sentence |
denotes |
Negative 60 (90.91%) 32 (45.71%) |
T148 |
1834-1866 |
Sentence |
denotes |
Positive 6 (9.09%) 38 (54.29%) |
T149 |
1867-1893 |
Sentence |
denotes |
Tree-in-bud sign < 0.001a* |
T150 |
1894-1928 |
Sentence |
denotes |
Negative 37 (56.06%) 61 (87.14%) |
T151 |
1929-1962 |
Sentence |
denotes |
Positive 29 (43.94%) 9 (12.86%) |
T152 |
1963-1989 |
Sentence |
denotes |
Pleural thickening 0.030a* |
T153 |
1990-2024 |
Sentence |
denotes |
Negative 46 (69.70%) 36 (51.43%) |
T154 |
2025-2059 |
Sentence |
denotes |
Positive 20 (30.30%) 34 (48.57%) |
T155 |
2060-2110 |
Sentence |
denotes |
Offending vessel augmentation in lesions < 0.001a* |
T156 |
2111-2145 |
Sentence |
denotes |
Negative 55 (83.33%) 17 (24.29%) |
T157 |
2146-2180 |
Sentence |
denotes |
Positive 11 (16.67%) 53 (75.71%) |
T158 |
2181-2207 |
Sentence |
denotes |
GGO ground-glass opacities |
T159 |
2208-2351 |
Sentence |
denotes |
#Results are median with interquartile range in parentheses, and the remainder results are measurements with corresponding ratio in parentheses |
T160 |
2352-2413 |
Sentence |
denotes |
*Data with statistical significance. pa: chi-square test, pb: |
T161 |
2414-2430 |
Sentence |
denotes |
Student’s t test |
T162 |
2431-2497 |
Sentence |
denotes |
Table 2 Clinical features of patients in COVID-19 and non-COVID-19 |
T163 |
2498-2553 |
Sentence |
denotes |
Feature Non-COVID-19 (n = 66) COVID-19 (n = 70) p value |
T164 |
2554-2557 |
Sentence |
denotes |
Sex |
T165 |
2558-2596 |
Sentence |
denotes |
Male# 43 (65.15%) 41 (58.57%) 0.430a |
T166 |
2597-2630 |
Sentence |
denotes |
Female# 23 (34.85%) 29 (41.43%) |
T167 |
2631-2679 |
Sentence |
denotes |
Age (years) 46.73 ± 25.00 42.93 ± 13.32 0.275b |
T168 |
2680-2691 |
Sentence |
denotes |
Vital signs |
T169 |
2692-2761 |
Sentence |
denotes |
Systolic blood pressure (mmHg) 126.92 ± 23.07 127.07 ± 15.16 0.965b |
T170 |
2762-2830 |
Sentence |
denotes |
Diastolic blood pressure (mmHg) 77.74 ± 15.72 80.39 ± 10.51 0.254b |
T171 |
2831-2891 |
Sentence |
denotes |
Respiration rate (bpm) 25.20 ± 7.29 19.86 ± 1.90 < 0.001b* |
T172 |
2892-2949 |
Sentence |
denotes |
Heart rate (bpm) 101.59 ± 20.36 86.06 ± 13.34 < 0.001b* |
T173 |
2950-3002 |
Sentence |
denotes |
Temperature (°C) 37.61 ± 1.06 37.12 ± 0.83 0.003b* |
T174 |
3003-3008 |
Sentence |
denotes |
Signs |
T175 |
3009-3053 |
Sentence |
denotes |
Dry cough# 56 (84.85%) 48 (68.57%) 0.025a* |
T176 |
3054-3095 |
Sentence |
denotes |
Fatigue# 8 (12.12%) 22 (31.43%) 0.007a* |
T177 |
3096-3138 |
Sentence |
denotes |
Sore throat# 6 (9.09%) 9 (12.86%) 0.483a |
T178 |
3139-3175 |
Sentence |
denotes |
Stuffy# 4 (6.06%) 2 (2.86%) 0.623a |
T179 |
3176-3216 |
Sentence |
denotes |
Runny nose# 3 (4.55%) 3 (4.29%) 0.731a |
T180 |
3217-3284 |
Sentence |
denotes |
White blood cell count (× 109/L) 11.48 ± 5.36 5.27 ± 2.33 < 0.001b* |
T181 |
3285-3326 |
Sentence |
denotes |
White blood cell count category < 0.001c* |
T182 |
3327-3353 |
Sentence |
denotes |
Low# 0 (0.00%) 2 (2.86%) |
T183 |
3354-3387 |
Sentence |
denotes |
Normal# 27 (40.91%) 63 (90.00%) |
T184 |
3388-3417 |
Sentence |
denotes |
High# 39 (59.09%) 5 (7.14%) |
T185 |
3418-3475 |
Sentence |
denotes |
Lymphocyte count (× 109/L) 1.57 ± 1.33 1.25 ± 0.68 0.086b |
T186 |
3476-3511 |
Sentence |
denotes |
Lymphocyte count category < 0.001c* |
T187 |
3512-3542 |
Sentence |
denotes |
Low# 24 (36.36%) 32 (45.71%) |
T188 |
3543-3576 |
Sentence |
denotes |
Normal# 35 (53.03%) 37 (52.86%) |
T189 |
3577-3605 |
Sentence |
denotes |
High# 7 (10.61%) 1 (1.43%) |
T190 |
3606-3666 |
Sentence |
denotes |
Neutrophil count (× 109/L) 8.97 ± 4.90 3.53 ± 2.17 < 0.001b* |
T191 |
3667-3702 |
Sentence |
denotes |
Neutrophil count category < 0.001c* |
T192 |
3703-3730 |
Sentence |
denotes |
Low# 3 (4.55%) 8 (11.43%) |
T193 |
3731-3764 |
Sentence |
denotes |
Normal# 23 (34.85%) 59 (84.29%) |
T194 |
3765-3794 |
Sentence |
denotes |
High# 40 (60.61%) 3 (4.29%) |
T195 |
3795-3858 |
Sentence |
denotes |
C-reactive protein (mg/L) 69.30 ± 65.88 26.37 ± 30.97 < 0.001b* |
T196 |
3859-3912 |
Sentence |
denotes |
Procalcitonin (ng/mL) 3.36 ± 8.98 0.26 ± 0.84 0.007b* |
T197 |
3913-3974 |
Sentence |
denotes |
*Data with statistical significance. pa: chi-square test, pb: |
T198 |
3975-3996 |
Sentence |
denotes |
Student’s t test. pc: |
T199 |
3997-4018 |
Sentence |
denotes |
Kruskal-Wallis H test |
T200 |
4019-4084 |
Sentence |
denotes |
#Results are measurements with corresponding ratio in parentheses |